Caughey W S, Raymond L D, Horiuchi M, Caughey B
Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12117-22. doi: 10.1073/pnas.95.21.12117.
A central aspect of pathogenesis in the transmissible spongiform encephalopathies or prion diseases is the conversion of normal protease-sensitive prion protein (PrP-sen) to the abnormal protease-resistant form, PrP-res. Here we identify porphyrins and phthalocyanines as inhibitors of PrP-res accumulation. The most potent of these tetrapyrroles had IC50 values of 0.5-1 microM in scrapie-infected mouse neuroblastoma (ScNB) cell cultures. Inhibition was observed without effects on protein biosynthesis in general or PrP-sen biosynthesis in particular. Tetrapyrroles also inhibited PrP-res formation in a cell-free reaction composed predominantly of hamster PrP-res and PrP-sen. Inhibitors were found among phthalocyanines, deuteroporphyrins IX, and meso-substituted porphines; examples included compounds containing anionic, neutral protic, and cationic peripheral substituents and various metals. We conclude that certain tetrapyrroles specifically inhibit the conversion of PrP-sen to PrP-res without apparent cytotoxic effects. The inhibition observed in the cell-free conversion reaction suggests that the mechanism involved direct interactions of the tetrapyrrole with PrP-res and/or PrP-sen. These findings introduce a new class of inhibitors of PrP-res formation that represents a potential source of therapeutic agents for transmissible spongiform encephalopathies.
传染性海绵状脑病或朊病毒疾病发病机制的一个核心方面是正常的蛋白酶敏感型朊病毒蛋白(PrP-sen)转变为异常的蛋白酶抗性形式PrP-res。在此,我们确定卟啉和酞菁为PrP-res积累的抑制剂。在感染羊瘙痒病的小鼠神经母细胞瘤(ScNB)细胞培养物中,这些四吡咯中最有效的IC50值为0.5 - 1微摩尔。观察到抑制作用,且一般对蛋白质生物合成无影响,尤其对PrP-sen生物合成无影响。四吡咯在主要由仓鼠PrP-res和PrP-sen组成的无细胞反应中也抑制PrP-res的形成。在酞菁、原卟啉IX和中位取代卟吩中发现了抑制剂;实例包括含有阴离子、中性质子化和阳离子外围取代基以及各种金属的化合物。我们得出结论,某些四吡咯特异性抑制PrP-sen向PrP-res的转变,且无明显细胞毒性作用。在无细胞转化反应中观察到的抑制作用表明,其机制涉及四吡咯与PrP-res和/或PrP-sen的直接相互作用。这些发现引入了一类新的PrP-res形成抑制剂,其代表了传染性海绵状脑病治疗药物的潜在来源。